BULLISHWHALES
Quantellect · Congress · Issuer Profile
NYSE: CLColgate-Palmolive Company
Consumer DefensiveMkt Cap $73.81BCongress ownership rank #121

Colgate-Palmolive Company Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 239 trades in Colgate-Palmolive Company (NYSE: CL) since 2013, across 41 members, worth an estimated $3.7M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 128 buys against 111 sells, a modestly buy-led skew, with Democratic members responsible for 55% of the trades and Republican members 45%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most CL transactions among those shown, with 26. Other recent filers include Rick Larsen, Julie Johnson, and Lisa McClain. One notable disclosed move was a purchase by Rohit Khanna on November 3, 2025, up 22.9% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Colgate-Palmolive Company (CL) stock overview and the complete trade table below.

Data updated

Trades
33
Politicians
6
Filings
16
Disclosed Vol
$386.52K
Buys
14
42%
Sells
19
58%

Price & congressional trade timeline

Party breakdown

Colgate-Palmolive congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Jul 6, 2026Jun 2, 202634 daysBUY
$1,001 - $15,000
+3.13%Dependent Child
Jun 9, 2026May 27, 202613 daysBUY
$1,001 - $15,000
-0.28%Spouse
Jun 9, 2026May 15, 202625 daysBUY
$1,001 - $15,000
+3.29%Spouse
Feb 6, 2026Jan 29, 20268 daysSELL
$1,001 - $15,000
+7.46%Spouse
Feb 6, 2026Jan 22, 202615 daysSELL
$15,001 - $50,000
+6.74%Dependent Child
Feb 6, 2026Jan 22, 202615 daysSELL
$1,001 - $15,000
+6.74%Dependent Child
Feb 6, 2026Jan 13, 202624 daysBUY
$1,001 - $15,000
+11.09%Spouse
Feb 6, 2026Jan 6, 202631 daysSELL
$1,001 - $15,000
+19.37%Dependent Child
Jan 6, 2026Dec 30, 20257 daysBUY
$1,001 - $15,000
+15.91%Spouse
Jan 6, 2026Dec 30, 20257 daysBUY
$1,001 - $15,000
+15.91%Dependent Child
Go to

Colgate-Palmolive (CL) congressional trading FAQ

Can members of Congress legally trade Colgate-Palmolive (CL) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Colgate-Palmolive (CL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Colgate-Palmolive (CL) trades public?

Yes. Every congressional trade in Colgate-Palmolive (CL) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Colgate-Palmolive (CL)?

Members of Congress have disclosed 239 trades in Colgate-Palmolive (CL) worth $3.7M across 41 members, according to public STOCK Act filings.

Which members of Congress have traded Colgate-Palmolive (CL)?

Recent and active filers of Colgate-Palmolive (CL) disclosures include Rohit Khanna, Lisa McClain, Rick Larsen. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Colgate-Palmolive (CL) more?

Across disclosed Colgate-Palmolive (CL) trades, 55% were by Democrats and 45% by Republicans, led by Democrats (55%).

What is the most recent congressional Colgate-Palmolive (CL) trade?

The most recent disclosed Colgate-Palmolive (CL) trade was a purchase by Rohit Khanna, filed Jul 5, 2026.

Browse all stocks Congress tradesCongressional trading overviewColgate-Palmolive (CL) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30